AVLN Avalyn Pharma Inc.

NASDAQ
$29.76

Avalyn Pharma Inc. (AVLN) is expected to report earnings on February 11, 2027, before the market open. The consensus earnings estimate is a loss of $0.70 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -3.0% since its last earnings release on November 12, 2026.

Avalyn Pharma Missed Consensus Estimates
Thursday, November 12, 2026 · 8:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · 8:00 AM ET
Earnings Whisper
-
vs ($0.70)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $30.27

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.